Second-line chemotherapy for advanced biliary tract cancer: Results of a multicenter survey

被引：0
|
作者：
Vasile, E. [1 ]
Di Girolamo, S. [2 ]
Cereda, S. [3 ]
Lonardi, S. [4 ]
Leone, F. [5 ]
Russano, M. [6 ]
Silvestris, N. [7 ]
Vivaldi, C. [1 ]
Fornaro, L. [8 ]
Brandi, G. [2 ]
机构：
[1] Azienda Osped Univ Pisana, Pisa, Italy
[2] Univ Bologna, St Orsola Malpighi Hosp, Bologna, Italy
[3] Ist Sci San Raffaele, I-20132 Milan, Italy
[4] Ist Oncol Veneto, Padua, Italy
[5] Univ Turin, Inst Canc Res & Treatment IRCC Candiolo, Turin, Italy
[6] Campus Biomed Univ, Rome, Italy
[7] IRCCS Osped Oncol, Inst Canc Res & Treatment, Bari, Italy
[8] Azienda USL 2, Lucca, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2585
引用
收藏
页码：S614 / S614
页数：1
相关论文
共 50 条
  • [41] Second-line chemotherapy in advanced bladder cancer
    Pavone-Macaluso, M
    Sternberg, C
    [J]. UROLOGIA INTERNATIONALIS, 2000, 64 (02) : 61 - 69
  • [42] Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data
    Lorenzo Fornaro
    Caterina Vivaldi
    Stefano Cereda
    Francesco Leone
    Giuseppe Aprile
    Sara Lonardi
    Nicola Silvestris
    Daniele Santini
    Michele Milella
    Chiara Caparello
    Gianna Musettini
    Giulia Pasquini
    Alfredo Falcone
    Giovanni Brandi
    Isabella Sperduti
    Enrico Vasile
    [J]. Journal of Experimental & Clinical Cancer Research, 34
  • [43] Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data
    Fornaro, Lorenzo
    Vivaldi, Caterina
    Cereda, Stefano
    Leone, Francesco
    Aprile, Giuseppe
    Lonardi, Sara
    Silvestris, Nicola
    Santini, Daniele
    Milella, Michele
    Caparello, Chiara
    Musettini, Gianna
    Pasquini, Giulia
    Falcone, Alfredo
    Brandi, Giovanni
    Sperduti, Isabella
    Vasile, Enrico
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2015, 34
  • [44] Second-line chemotherapy (2L) in elderly patients with advanced biliary tract cancer (ABC): A multicenter real-world study.
    Rizzo, Alessandro
    Salati, Massimiliano
    Frega, Giorgio
    Merz, Valeria
    Caputo, Francesco
    Ricci, Angela Dalia
    Palloni, Andrea
    Messina, Carlo
    Spallanzani, Andrea
    Saccoccio, Gioconda
    Mollica, Veronica
    Gelsomino, Fabio
    Benatti, Stefania
    Luppi, Gabriele
    Melisi, Davide
    Dominici, Massimo
    Brandi, Giovanni
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [45] Towards establishing the standard of care for second-line therapy in advanced biliary tract cancer
    Beal, Eliza W.
    [J]. LANCET ONCOLOGY, 2021, 22 (11): : 1488 - 1490
  • [46] Second-line chemotherapy in patients with advanced or recurrent biliary tract cancer: a single center, retrospective analysis of 294 cases
    Takahara, Naminatsu
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Saito, Kei
    Oyama, Hiroki
    Kanai, Sachiko
    Suzuki, Tatsunori
    Sato, Tatsuya
    Hakuta, Ryunosuke
    Ishigaki, Kazunaga
    Takeda, Tsuyoshi
    Saito, Tomotaka
    Mizuno, Suguru
    Kogure, Hirofumi
    Tada, Minoru
    Koike, Kazuhiko
    [J]. INVESTIGATIONAL NEW DRUGS, 2018, 36 (06) : 1093 - 1102
  • [47] FOLFIRI-bevacizumab as a second-line treatment for advanced biliary tract cancer after gemcitabine-based chemotherapy
    Roussot, Nicolas
    Vincent, Julie
    Palmier, Remi
    Constantin, Guillaume
    Bengrine, Leila
    Fumet, Jean-David
    Ghiringhelli, Francois
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [48] Second-line chemotherapy in patients with advanced or recurrent biliary tract cancer: a single center, retrospective analysis of 294 cases
    Naminatsu Takahara
    Yousuke Nakai
    Hiroyuki Isayama
    Takashi Sasaki
    Kei Saito
    Hiroki Oyama
    Sachiko Kanai
    Tatsunori Suzuki
    Tatsuya Sato
    Ryunosuke Hakuta
    Kazunaga Ishigaki
    Tsuyoshi Takeda
    Tomotaka Saito
    Suguru Mizuno
    Hirofumi Kogure
    Minoru Tada
    Kazuhiko Koike
    [J]. Investigational New Drugs, 2018, 36 : 1093 - 1102
  • [49] SECOND-LINE CHEMOTHERAPY WITH S-1 AFTER CISPLATIN AND GEMCITABINE FAILURE IN PATIENTS WITH ADVANCED BILIARY TRACT CANCER
    Ueda, Shinya
    Kawakami, Hisato
    Okamoto, Wataru
    Nishina, Shinichi
    Kudo, Toshihiro
    Makimura, Chihiro
    Kiyota, Hidemi
    Tanaka, Kaoru
    Kaneda, Hiroyasu
    Fujisaka, Yasuhito
    Miyazaki, Masaki
    Turutani, Junji
    Okamoto, Isamu
    Kurata, Takayasu
    Nakagawa, Kazuhiko
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 65 - 65
  • [50] Second-line chemotherapy for advanced bladder cancer: A survey of current UK practice
    Lamb, Benjamin W.
    Vasdev, Nikhil
    Jalil, Rozh T.
    McMenemin, Rhona
    Hughes, Simon
    Payne, Heather
    Green, James S. A.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 52.e11 - 52.e17
12345